Background material:

CIRM held a Roundtable meeting on Immune Response with the FDA in October of 2011. Materials from that meeting are here.

In June 2010 CIRM committed $25 million to overcome immune rejection of stem cell transplantation therapies. More information on the 19 awards in RFA 09-03, CIRM Stem Cell Transplantation Immunology Awards, can be found on our press release.